Skip main navigation

Military Health System

Clear Your Cache

Health.mil has undergone a recent update. For the best user experience we recommend clearing your browser cache.

Mid-Season Influenza Vaccine Effectiveness Estimates Among DOD Populations: A Composite of Data Presented at VRBPAC—the Vaccines and Related Biological Products Advisory Committee—2024 Meeting on Influenza Vaccine Strain Selection for the 2024-2025 Influenza Season

Image of 48088663. The Department of Defense participates in the annual Vaccines and Related Biological Products Advisory Committee meeting by presenting its mid-season influenza data.

Each March, the Vaccines and Related Biological Products Advisory Committee of the U.S. Food and Drug Agency meets to review and discuss data on influenza strain circulation and vaccine effectiveness estimates for the current influenza season.1 The committee then makes recommendations on the selection of strains for the influenza vaccines to be developed for the following influenza season. 

The Department of Defense participates in the VRBPAC meeting by presenting mid-season influenza data from the DOD’s global influenza surveillance, VE, and phylogenetic analyses, in addition to antigenic characterization of circulating viruses. DOD VE analyses are conducted among both service member and non-service member beneficiary populations to complement U.S. population VE estimates.2 

Timing of these analyses is dependent upon the timing of peak activity for each season. Typically, mid-season estimates cannot be generated until February, to allow for adequate testing and sufficient case numbers to provide a reliable sample size for analysis.

These DOD VE analyses represent a joint effort between the Defense Health Agency's Defense Centers for Public Health in Falls Church and Dayton and the Naval Health Research Center. The combined assessment of data from these organizations provides the DOD, FDA, and U.S. Centers for Disease Control with comprehensive mid-season information on how well the influenza vaccines are working for force health protection and the broader military health population. 

MSMR anticipates publishing these findings annually, in February or March, to disseminate this information more widely to interested individuals and public health agencies. 

Author Affiliations

Epidemiology and Analysis Branch, Armed Forces Health Surveillance Division, Defense Health Agency: Dr. Eick-Cost, Ms. Hu; Defense Centers for Public Health–Dayton, Defense Health Agency: Mr. Thervil, Ms. DeMarcus 

Disclaimer

The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views, assertions, opinions, nor policies of the Defense Health Agency or the Department of Defense. 

References

  1. U.S. Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee May 16, 2024 Meeting Announcement. https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-may-16-2024-meeting-announcement 
  2. McLean HQ, Petrie JG, Hanson KE, et al. Interim estimates of 2022-23 seasonal influenza vaccine effectiveness–Wisconsin, October 2022-February 2023. MMWR Morb Mortal Wkly Rep. 2023;72:201-205.

You also may be interested in...

Article
Apr 25, 2025

Medical Surveillance Monthly Report "30th Anniversary" Issue Celebrates a Milestone

MSMR 30th anniversary issue celebrates a milestone

This year marks a significant milestone for the Medical Surveillance Monthly Report as we celebrate its 30th anniversary. Throughout its three decades, MSMR has continuously improved its content with the goal of providing readers with unbiased, scientifically rigorous, evidence-based medical surveillance information on the current status, trends, ...

Article
Apr 1, 2025

Guest Editorial: The Department of Defense Global Respiratory Pathogen Surveillance Program: Its Impact on Public Health, from the U.S. Armed Forces to Global Health

This editorial discusses the U.S. Department of Defense Global Respiratory Pathogen Surveillance Program, a cornerstone of U.S. Department of Defense respiratory disease surveillance, and its surveillance network of 115 active sentinel sites in addition to other participating sites, deployed locations, and partner laboratories across the globe.

Article
Mar 1, 2025

Correlation Between Mean Temperature and Incidence of Tick-borne Diseases Among Active Duty Service Members in the Contiguous U.S., 2000–2023

This study identifies the incidence of the two tick-borne diseases, Lyme disease and Rocky Mountain spotted fever, that are most frequently diagnosed within the Military Health System among active component U.S. service members and evaluates the correlation between temperature and incidence of each tick-borne disease.

Article
Mar 1, 2025

Non-Medical Risk Factors Influencing Health and Association with Suicidal Ideation or Attempt, U.S. Active Component, 2018–2022

This study reports the prevalence of non-medical risk factors, also known as social determinants of health, among active component U.S. service members and assesses the relationship between these factors and suicide ideation or attempts between 2018 and 2022. This study documents, for the first time, the frequency of diagnosis for non-medical risk ...

Skip subpage navigation
Refine your search
Last Updated: May 07, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Subscribe to updates from the MHS